BioSpace News Archive

Bio NC

1Q2019 Life Science Growth Announcements

In the first quarter of 2019, more than 30 life science companies* announced expansions, new locations, increased funding, new trial and product launches and various other news pointing to a growing industry.

April 17, 2019
·
2 min read
·
Editorial Staff
Pharm Country

Lannett Shares Fall After Article Raises Questions Regarding Anti-Trust Lawsuits and Potential Fines

The pseudonym-penned article contends 2013 and 2014 price increases for two Lannett Drugs were part of a multi-company price-fixing scheme.

April 17, 2019
·
2 min read
·
Alex Keown
Deals

Kiadis Will Marry Its T-Cell Platform to CytoSen’s NK-Cell Platform in All-Stock Deal

The combination of the two companies will create a leader in cell-based cancer immunotherapy, Kiadis said. It also further expands Kiadis’ toehold in the United States.

April 17, 2019
·
3 min read
·
Alex Keown
Deals

Notice of Annual General Meeting in Promore Pharma AB (publ)

Promore Pharma AB calls for Annual General Meeting Tuesday 21 May 2019 at 2 pm at Wenner-Gren Center, Biblioteket, plan 24, Sveavägen 166, in Stockholm.

April 17, 2019
·
8 min read
Quantum dot imaging advances

Luminescing nanosized crystals are showing promise for peering deeply into body tissues, but first they need to be made safe.

April 17, 2019
·
2 min read
FDA

Ultragenyx Announces UX007 Granted Fast Track Designation and Rare Pediatric Disease Designation by U.S. FDA for Treatment of Long-Chain Fatty Acid Oxidation Disorders

Company on Track to Submit NDA to FDA in Mid-2019

April 17, 2019
·
5 min read
Policy

Bioprinting: Poietis announces the award of a third new major European patent

Poietis, 4D Bioprinting company, announces the issuance by the European Patent Office of a third patent covering its bioprinting technology

April 17, 2019
·
2 min read
Drug Development

MediciNova Announces Plans to Move Forward with a Phase 3 Trial of MN-166 (ibudilast) in ALS

MediciNova, Inc. announced that the U.S. Food and Drug Administration has completed its review of the protocol and determined that MediciNova may proceed with a Phase 2b/3 clinical trial of MN-166 in amyotrophic lateral sclerosis.

April 17, 2019
·
7 min read
Deals

CEVEC closes major financing round to further expand and commercialize its viral vector manufacturing platform

CEVEC Pharmaceuticals GmbH announced the successful closing of a Series D financing round with new and existing investors.

April 17, 2019
·
3 min read
TreeFrog Therapeutics delivers first batch of Stem Cells (hIPS), with best-in-class quality check, to cell and gene therapy leader Imagine Institute

Based on biomimetic stem cell culture in 3D, C-Stem™ enables cell therapy production scale-up while ensuring genomic and phenotypic stability

April 17, 2019
·
3 min read